• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 69-83 of 133 results

1042 Exhibit: MYLAN EX 1042 US Provisional Application No 60080,274

Document IPR2017-01034, No. 1042 Exhibit - MYLAN EX 1042 US Provisional Application No 60080,274 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1049 Exhibit: MYLAN EX 1049 Uceris¿¿ Instant Savings Program

Document IPR2017-01034, No. 1049 Exhibit - MYLAN EX 1049 Uceris¿¿ Instant Savings Program (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1055 Exhibit: MYLAN EX 1055 Specification of 13249,839 application

Document IPR2017-01034, No. 1055 Exhibit - MYLAN EX 1055 Specification of 13249,839 application (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1008 Exhibit: MYLAN EX 1008 US Patent No 5,681,584

Document IPR2017-01034, No. 1008 Exhibit - MYLAN EX 1008 US Patent No 5,681,584 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1024 Exhibit: MYLAN EX 1024 PCT International Publication No WO 9939700,

Document IPR2017-01034, No. 1024 Exhibit - MYLAN EX 1024 PCT International Publication No WO 9939700, (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1032 Exhibit: MYLAN EX 1032 Entocort¿¿ EC Highlights of Prescribing Information

Document IPR2017-01034, No. 1032 Exhibit - MYLAN EX 1032 Entocort¿¿ EC Highlights of Prescribing Information (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1034 Exhibit: MYLAN EX 1034 US Patent No 6,395,300

Document IPR2017-01034, No. 1034 Exhibit - MYLAN EX 1034 US Patent No 6,395,300 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1050 Exhibit: MYLAN EX 1050 Transcript of the Second Quarter 2014 Earnings Co...

Document IPR2017-01034, No. 1050 Exhibit - MYLAN EX 1050 Transcript of the Second Quarter 2014 Earnings Conference Call of Salix Pharmaceuticals, Ltd (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1046 Exhibit: MYLAN EX 1046 M Efentakis et al

Document IPR2017-01034, No. 1046 Exhibit - MYLAN EX 1046 M Efentakis et al (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1059 Exhibit: MYLAN EX 1059 Original Specification as field on September 14, 201...

Document IPR2017-01034, No. 1059 Exhibit - MYLAN EX 1059 Original Specification as field on September 14, 2012 in US Patent Appl No 13617,138 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1056 Exhibit: MYLAN EX 1056 Specification of 13462,409 application

Document IPR2017-01034, No. 1056 Exhibit - MYLAN EX 1056 Specification of 13462,409 application (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1060 Exhibit: MYLAN EX 1060 Orange Book Listing of Uceris

Document IPR2017-01034, No. 1060 Exhibit - MYLAN EX 1060 Orange Book Listing of Uceris (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1057 Exhibit: MYLAN EX 1057 Final Office Action of March 6, 2013 in US Patent Ap...

Document IPR2017-01034, No. 1057 Exhibit - MYLAN EX 1057 Final Office Action of March 6, 2013 in US Patent Appl No 13617,138 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1037 Exhibit: MYLAN EX 1037 US Patent No 4,880,830

Document IPR2017-01034, No. 1037 Exhibit - MYLAN EX 1037 US Patent No 4,880,830 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1048 Exhibit: MYLAN EX 1048 Santarus¿¿¿ CEO Discusses FDA Approval Of UCER...

Document IPR2017-01034, No. 1048 Exhibit - MYLAN EX 1048 Santarus¿¿¿ CEO Discusses FDA Approval Of UCERIS (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 9 10 >>